Pérez-Torras S - Search Results

1

Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

Pérez-Torras S, García-Manteiga J, Mercadé E, Casado FJ, Carbó N, Pastor-Anglada M, Mazo A. Pérez-Torras S, et al. Biochem Pharmacol. 2008 Aug 1;76(3):322-9. doi: 10.1016/j.bcp.2008.05.011. Epub 2008 May 20. Biochem Pharmacol. 2008. PMID: 18589402

2

Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy.

Blasco F, Peñuelas S, Cascalló M, Hernández JL, Alemany C, Masa M, Calbó J, Soler M, Nicolás M, Pérez-Torras S, Gómez A, Tarrasón G, Noé V, Mazo A, Ciudad CJ, Piulats J. Blasco F, et al. Oncology. 2004;67(3-4):277-90. doi: 10.1159/000081329. Oncology. 2004. PMID: 15557790

3

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

Marchán S, Pérez-Torras S, Vidal A, Adan J, Mitjans F, Carbó N, Mazo A. Marchán S, et al. Anal Cell Pathol (Amst). 2010;33(5):191-205. doi: 10.3233/ACP-CLO-2010-0538. Anal Cell Pathol (Amst). 2010. PMID: 20978323 Free PMC article.

4

Connexin-26 is a key factor mediating gemcitabine bystander effect.

Garcia-Rodríguez L, Pérez-Torras S, Carrió M, Cascante A, García-Ribas I, Mazo A, Fillat C. Garcia-Rodríguez L, et al. Mol Cancer Ther. 2011 Mar;10(3):505-17. doi: 10.1158/1535-7163.MCT-10-0693. Mol Cancer Ther. 2011. PMID: 21388975

5

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

Marchán S, Pérez-Torras S, Vidal A, Adan J, Mitjans F, Carbó N, Mazo A. Marchán S, et al. Cell Oncol (Dordr). 2011 Aug;34(4):393-405. doi: 10.1007/s13402-011-0039-3. Epub 2011 May 31. Cell Oncol (Dordr). 2011. PMID: 21626402

6

New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells.

Guillén-Gómez E, Pinilla-Macua I, Pérez-Torras S, Choi DS, Arce Y, Ballarín JA, Pastor-Anglada M, Díaz-Encarnación MM. Guillén-Gómez E, et al. J Cell Physiol. 2012 Apr;227(4):1521-8. doi: 10.1002/jcp.22869. J Cell Physiol. 2012. PMID: 21678404

7

Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening.

Pérez-Torras S, Vidal-Pla A, Miquel R, Almendro V, Fernández-Cruz L, Navarro S, Maurel J, Carbó N, Gascón P, Mazo A. Pérez-Torras S, et al. Cell Oncol (Dordr). 2011 Dec;34(6):511-21. doi: 10.1007/s13402-011-0049-1. Epub 2011 Jun 17. Cell Oncol (Dordr). 2011. PMID: 21681527 Free article.

8

Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia.

Errasti-Murugarren E, Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Pérez-Torras S, Kipp H, Koepsell H, Pastor-Anglada M. Errasti-Murugarren E, et al. Mol Pharmacol. 2012 Jul;82(1):59-67. doi: 10.1124/mol.111.076992. Epub 2012 Apr 9. Mol Pharmacol. 2012. PMID: 22492015

9

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.

Trigueros-Motos L, Pérez-Torras S, Casado FJ, Molina-Arcas M, Pastor-Anglada M. Trigueros-Motos L, et al. BMC Cancer. 2012 Sep 27;12:434. doi: 10.1186/1471-2407-12-434. BMC Cancer. 2012. PMID: 23017148 Free PMC article.

10

Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.

Pérez-Torras S, Vidal-Pla A, Cano-Soldado P, Huber-Ruano I, Mazo A, Pastor-Anglada M. Pérez-Torras S, et al. Cell Death Dis. 2013 May 30;4(5):e648. doi: 10.1038/cddis.2013.173. Cell Death Dis. 2013. PMID: 23722537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters